These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14618190)

  • 1. [Impetigo bullosa].
    Tveten Y
    Tidsskr Nor Laegeforen; 2003 Nov; 123(21):3089; author reply 3089. PubMed ID: 14618190
    [No Abstract]   [Full Text] [Related]  

  • 2. [An epidemic of bullous impetigo in the municipality of Austevoll in the year 2002].
    Rørtveit S; Rørtveit G
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2557-60. PubMed ID: 14714041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use.
    Weston VC; Boswell TC; Finch RG; Perkins W
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053928
    [No Abstract]   [Full Text] [Related]  

  • 4. Fusidic acid cream for impetigo. Findings cannot be extrapolated.
    Owen SE; Cheesbrough JS
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053931
    [No Abstract]   [Full Text] [Related]  

  • 5. Fusidic acid cream for impetigo. Problem may be clinically important.
    Stoddart B; Collyns T; Denton M
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053929
    [No Abstract]   [Full Text] [Related]  

  • 6. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41.
    Koning S; van Belkum A; Snijders S; van Leeuwen W; Verbrugh H; Nouwen J; Op 't Veld M; van Suijlekom-Smit LW; van der Wouden JC; Verduin C
    J Clin Microbiol; 2003 Jul; 41(7):3017-21. PubMed ID: 12843036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusidic acid cream for impetigo. Resistance trends must be monitored.
    Zadik P; Young N
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053930
    [No Abstract]   [Full Text] [Related]  

  • 8. Fusidic acid cream for impetigo. Judicious use is advisable.
    Sule O; Brown N; Brown DF; Burrows N
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053927
    [No Abstract]   [Full Text] [Related]  

  • 9. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics.
    Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
    J Antimicrob Chemother; 2011 Jun; 66(6):1360-4. PubMed ID: 21393202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusidic acid cream for impetigo. Fusidic acid should be used with restraint.
    Brown EM; Wise R
    BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12052817
    [No Abstract]   [Full Text] [Related]  

  • 11. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.
    Laurent F; Tristan A; Croze M; Bes M; Meugnier H; Lina G; Vandenesch F; Etienne J
    J Antimicrob Chemother; 2009 Feb; 63(2):420-1; author reply 421. PubMed ID: 18978362
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia.
    Alreshidi MA; Mariana NS
    Med J Malaysia; 2011 Aug; 66(3):276. PubMed ID: 22111461
    [No Abstract]   [Full Text] [Related]  

  • 13. Fusidic acid resistant Staphylococcus aureus and skin disease.
    Lomholt HB
    Acta Derm Venereol; 2010; 90(1):4. PubMed ID: 20107716
    [No Abstract]   [Full Text] [Related]  

  • 14. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
    Alsterholm M; Flytström I; Bergbrant IM; Faergemann J
    Acta Derm Venereol; 2010; 90(1):52-7. PubMed ID: 20107726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
    Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
    Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
    Liu Y; Kong F; Zhang X; Brown M; Ma L; Yang Y
    Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current options for the treatment of impetigo in children.
    Sladden MJ; Johnston GA
    Expert Opin Pharmacother; 2005 Oct; 6(13):2245-56. PubMed ID: 16218885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of impetigo: save mupirocin.
    Axelsson I
    BMJ; 2004 Oct; 329(7472):979. PubMed ID: 15499129
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
    Apisarnthanarak A; Mundy LM
    Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.